MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
1992 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
24.6 M |
Market Cap[1] |
$ 3.96 B |
EBITDA (LTM) |
$ 244 M |
P/E (LTM) |
5586.0 |
P/S (LTM) |
1.850599 |
EPS (LTM) |
0.03 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 194.34 | 0.3 % | $ 55.9 B | NYSE,SPB | USA |
 |
Alcon
ALC
|
$ 67.43 | -0.58 % | $ 33.3 B | NYSE |  Schweiz |
 |
Intuitive Surgical
ISRG
|
$ 428.12 | -2.26 % | $ 153 B | Nasdaq Global Select Market,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 3.11 | 2.3 % | $ 144 M | Nasdaq Capital Market | USA |
 |
AtriCure
ATRC
|
$ 57.67 | -0.23 % | $ 2.75 B | Nasdaq Global Market,SPB | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Scientific
MLSS
|
$ 0.31 | -8.31 % | $ 25.4 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 91.4 | 0.24 % | $ 5.41 B | Nasdaq Global Select Market,SPB | USA |
 |
Nephros
NEPH
|
$ 3.59 | 1.99 % | $ 38.1 M | Nasdaq Global Select Market | USA |
 |
electroCore
ECOR
|
$ 7.35 | -1.87 % | $ 62.4 K | Nasdaq Global Select Market | USA |
 |
Envista Holdings Corporation
NVST
|
$ 23.19 | 0.96 % | $ 3.9 B | NYSE | USA |
 |
Baxter International
BAX
|
$ 24.7 | 0.78 % | $ 12.7 B | NYSE,SPB | USA |
 |
Pro-Dex
PDEX
|
$ 60.56 | 1.96 % | $ 195 B | Nasdaq Global Select Market | USA |
 |
Pulse Biosciences
PLSE
|
$ 51.31 | 0.92 % | $ 3.46 B | Nasdaq Global Select Market | USA |
 |
Repligen Corporation
RGEN
|
$ 180.01 | 0.63 % | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Retractable Technologies
RVP
|
$ 0.58 | -0.02 % | $ 17.4 M | NYSE American | USA |
 |
STAAR Surgical Company
STAA
|
$ 21.61 | -3.18 % | $ 1.07 B | Nasdaq Global Market,SPB | USA |
 |
STERIS plc
STE
|
$ 221.48 | -1.58 % | $ 21.7 B | NYSE,SPB | USA |
 |
Stereotaxis
STXS
|
$ 0.99 | -0.34 % | $ 90 M | NYSE American | USA |
 |
InfuSystem Holdings
INFU
|
$ 14.05 | -1.26 % | $ 290 M | NYSE American | USA |
 |
Glaukos Corporation
GKOS
|
$ 176.85 | 1.97 % | $ 10.1 B | NYSE,SPB | USA |
 |
Utah Medical Products
UTMD
|
$ 74.72 | -0.47 % | $ 242 M | Nasdaq Global Select Market | USA |
 |
AngioDynamics
ANGO
|
$ 11.89 | 0.68 % | $ 494 M | Nasdaq Global Select Market | USA |
 |
Haemonetics Corporation
HAE
|
$ 117.11 | -0.93 % | $ 5.53 B | NYSE,SPB | USA |
 |
West Pharmaceutical Services
WST
|
$ 393.48 | 1.21 % | $ 28.4 B | NYSE,SPB | USA |
 |
iRhythm Technologies
IRTC
|
$ 113.55 | -0.26 % | $ 3.63 B | Nasdaq Global Select Market,SPB | USA |
 |
LeMaitre Vascular
LMAT
|
$ 83.67 | 0.32 % | $ 1.89 B | Nasdaq Global Market,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 8.49 | 1.8 % | $ 377 M | Nasdaq Global Market | USA |
 |
ResMed
RMD
|
$ 246.2 | 0.31 % | $ 35.8 B | NYSE,SPB | USA |
 |
OraSure Technologies
OSUR
|
$ 3.86 | 3.07 % | $ 284 M | Nasdaq Global Select Market,SPB | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 9.08 | 2.37 % | $ 1.81 B | Nasdaq Global Select Market,SPB | USA |
 |
Teleflex Incorporated
TFX
|
$ 130.4 | -0.57 % | $ 5.82 B | NYSE,SPB | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
The Cooper Companies
COO
|
$ 58.97 | -0.25 % | $ 11.7 B | NYSE,SPB | USA |
 |
Microbot Medical
MBOT
|
$ 0.94 | -0.78 % | $ 43 M | Nasdaq Global Select Market |  Israel |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.